Eli Lilly (LLY) Minority Interest (2009 - 2025)

Eli Lilly (LLY) has reported Minority Interest for 17 consecutive years, with $57.5 million the latest figure, recorded in Q3 2025.

• Minority Interest for Q3 2025 came in at $57.5 million, down 28.75% year-over-year; the trailing twelve-month figure through Sep 2025 was $57.5 million (down 28.75% YoY), and the FY2024 annual result was $79.5 million, down 13.4% from the prior year.
• Minority Interest was $57.5 million for Q3 2025 at Eli Lilly, down from $76.2 million in the prior quarter.
• Over five years, Minority Interest peaked at $219.1 million in Q2 2021 and troughed at $57.5 million in Q3 2025.
• Average Minority Interest over 5 years is $113.8 million, with a median of $91.8 million recorded in 2023.
• Year-over-year, Minority Interest soared 69.43% in 2021 and tumbled 51.4% in 2022.
• Over 5 years, Minority Interest stood at $175.6 million in 2021, then slipped by 28.47% to $125.6 million in 2022, then declined by 26.91% to $91.8 million in 2023, then dropped by 13.4% to $79.5 million in 2024, then fell by 27.67% to $57.5 million in 2025.
• Per Business Quant data, the three most recent Minority Interest figures were $57.5 million in Q3 2025, $76.2 million in Q2 2025, and $82.0 million in Q1 2025.